An elevated progastrin-releasing peptide level in patients with well-differentiated neuroendocrine tumours indicates a primary tumour in the lung and predicts a shorter survival

Autor: Korse, C.M. ^*, Taal, B.G., Bonfrer, J.M.G., Vincent, A., van Velthuysen, M.L., Baas, P.

Publikováno v: In Annals of Oncology December 2011 22(12):2625-2630

Epidemiology and survival in patients with carcinoid disease in the Netherlands: An epidemiological study with 2391 patients

Autor: Quaedvlieg, P.F.H.J., Visser, O., Lamers, C.B.H.W., Janssen-Heijen, M.L.G., Taal, B.G. ^*

Publikováno v: In Annals of Oncology September 2001 12(9):1295-1300

Sequence-dependent toxicity profile in modified famtx (fluorouracil-adriamycin-methotrexate) chemotherapy with lenograstim support for advanced gastric cancer: a feasibility study

Autor: Westermann, A.M., Taal, B.G., Swart, M., Boot, H., Craanen, M., Gerritsen, W.R. ²

Publikováno v: In Pharmacological Research August 2000 42(2):151-156

Searching for New Biomarkers of Neuroendocrine Tumors: A Comparative Analysis of Chromogranin A and Inflammatory Cytokines in Patients with Neuroendocrine Tumors.

Autor: Budek, Marlena¹ (AUTHOR) marlenamarkiewicz@o2.pl, Nuszkiewicz, Jarosław¹ (AUTHOR) jnuszkiewicz@cm.umk.pl, Czuczejko, Jolanta^2,3 (AUTHOR) joczu@cm.umk.pl, Maruszak-Parda, Marta³ (AUTHOR), Wróblewska, Joanna¹ (AUTHOR) joanna.wroblewska@cm.umk.pl, Wojtasik, Jakub⁴ (AUTHOR) jwojtasik@umk.pl, Hołyńska-Iwan, Iga⁵ (AUTHOR) igaholynska@cm.umk.pl, Pawłowska, Marta¹ (AUTHOR) marta.pawlowska@cm.umk.pl, Woźniak, Alina¹ (AUTHOR) al1103@cm.umk.pl, Szewczyk-Golec, Karolina¹ (AUTHOR) karosz@cm.umk.pl

Publikováno v: Current Oncology. Oct2024, Vol. 31 Issue 10, p6110-6132. 23p.

Colorectal cancer risk in HNPCC families: Development during lifetime and in successive generations

Autor: Voskuil, D.W., Vasen, H.F.A., Kampman, E., van 't Veer, P., Griffioen, G., Kleibeuker, J.H., Meera Khan, P., Menko, F.H., Nagengast, F.M., Taal, B.G.

Publikováno v: International Journal of Cancer 72 (1997)
International Journal of Cancer, 72, 205-209. Wiley-Liss Inc.
Voskuil, D W, Vasen, H F A, Kampman, E, van 't Veer, P, Griffioen, G, Kleibeuker, J H, Meera Khan, P, Menko, F H, Nagengast, F M & Taal, B G 1997, ' Colorectal cancer risk in HNPCC families: development during lifetime and in successive generations ', International Journal of Cancer, vol. 72, pp. 205-209 . https://doi.org/10.1002/(SICI)1097-0215(19970717)72:2<205::AID-IJC1>3.0.CO;2-V
International Journal of Cancer, 72, 205-209

Members of hereditary non-polyposis colorectal cancer (HNPCC) families develop colorectal cancer at a much higher rate, and at a much younger age, than the general population. To quantify lifetime colorectal cancer risk in HNPCC family members, we ca

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe40486e0c3fea0d289b24fad3df96d9
https://doi.org/10.1002/(sici)1097-0215(19970717)72:2<205::aid-ijc1>3.0.co